Emirates Drug Agency rolls out third-party storage 3PL option for medical warehouses
The Emirates Drug Agency announced the introduction of third-party storage 3PL as a licensing option within its medical warehouse licensing services, allowing applicants to contract with licensed medical warehouses instead of building standalone storage facilities. The change was confirmed in a press release from the agency and applies to facilities across the United Arab Emirates seeking distribution privileges.
The agency said it has already begun inspecting submitted applications and collecting stakeholder feedback to adapt operational scenarios, checklists and regulatory requirements. The move aims to streamline approvals while maintaining compliance with Good Distribution Practice standards, officials said.
What the third-party storage 3PL model requires
Under the new framework, applicants for storage permission must sign an agreement with at least one logistics provider that qualifies as a third-party logistics operator, defined by the agency as an existing medical warehouse holding a valid licence from the Emirates Drug Agency. Therefore, a license applicant can demonstrate distribution capability by partnering with an authorized 3PL rather than investing in a separate storage site.
Additionally, the agency clarified that contracts must reflect responsibilities for temperature control, security, recordkeeping and incident reporting. These provisions are intended to ensure contracted facilities meet the same sanitary and regulatory conditions as in-house warehouses under the agency’s medical warehouse licensing process.
Why the agency adopted third-party storage 3PL
Officials cited cost efficiency and better use of existing logistical capacity as key drivers for the policy change. By enabling licensed firms to use compliant third-party storage, the agency expects reductions in upfront capital expenditure and improved flexibility for companies expanding distribution services in the UAE.
Furthermore, the model is seen as supportive of small and medium-sized enterprises and start-ups that may lack the resources to construct facilities that comply with Good Distribution Practice. It also leverages established logistics infrastructure in the UAE and may attract foreign direct investment by lowering barriers to entry, industry analysts said.
Regulatory safeguards, inspections and alignment with Good Distribution Practice
The agency indicated that specialised inspection teams have begun field visits tied to the submitted applications, and that collected findings will inform updates to the regulatory framework. These inspections are intended to verify that contracted 3PL warehouses operate in accordance with applicable Good Distribution Practice principles and public health requirements.
Operational checks and updated guidance
According to the statement, the agency is developing operational scenarios and refining checklists specific to third-party arrangements. Therefore, regulatory staff will evaluate areas such as cold-chain integrity, traceability systems, contractual governance and contingency planning when reviewing applications under the medical warehouse licensing pathway.
Furthermore, the unified framework seeks to limit procedural exceptions and strengthen oversight. Officials noted that aligning local practice with international storage and distribution standards remains a priority as the agency updates its licensing templates.
Industry implications and benefits of third-party storage 3PL
Stakeholders are likely to experience immediate logistical and financial benefits from the third-party storage 3PL option. For licensed distributors, contracting with existing compliant warehouses can accelerate market entry and reduce inventory carrying costs while maintaining regulatory compliance.
For logistics providers, the policy expands the potential client base for licensed medical warehouses and could incentivise further investment in cold-chain and tracking technologies. Meanwhile, healthcare suppliers and patients stand to benefit from more resilient supply chains, as the model facilitates flexible storage capacity during demand fluctuations.
Secondary keywords such as medical warehouse licensing and logistics infrastructure are central to these outcomes, as the success of the approach depends on the availability of well-equipped, compliant storage operators across the UAE.
Stakeholder response and next steps to watch
The agency said it is actively gathering input from market participants and will incorporate feedback into the finalised licensing guidance. Industry representatives should expect updated checklists and operational guidance to be published in due course, according to the press release.
Companies interested in the model are advised to review existing licensing criteria for medical warehouse licensing and to begin assessing potential contractual arrangements with licensed logistics providers. Meanwhile, regulators will continue on-site verifications to ensure scaled implementation aligns with Good Distribution Practice.
Conclusion: What to expect moving forward
The Emirates Drug Agency’s adoption of the third-party storage 3PL model marks a regulatory shift intended to reduce costs, increase flexibility and strengthen supply chain resilience in the UAE. Over the coming months, stakeholders should monitor the agency’s updated guidance, inspection results and any licensing portal announcements.
Watch for published checklists and formal communications from the agency that will clarify timelines and operational requirements, and for further regulatory adjustments as authorities reconcile stakeholder feedback with international distribution standards.
